Gene Query: EEF2K

Dataset Description Geneva Score
EP400 is required for Max and MCPyV mediated gene activation 35.78
BAF controls genome accessibility 33.36
An integrative analysis of non-coding regulatory DNA variations associated with autism 33.08
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 30.55
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 29.89
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 28.86
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 28.08
RNA-seq analyisis of PUM2 knockout cells 26.31
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 25.86
The regulartory role of ZCCHC24 in splicing machinery 25.34
Transcriptome wide analysis of classically and alternatively activated macrophages 22.46
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 21.29
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 20.19
Oncogenic MYC induces a dependency on the spliceosome in human cancer 19.7
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 19.51
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 19.37
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 19.34
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 19.06
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 18.78
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 18.76
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 18.03
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 17.76
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 17.74
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 16.99
Developmental stage specific chromosome architecture in human erythroid cells 16.99
RNA-seq analysis of differentiating human erythroblasts 16.79
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 16.71
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 15.84
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 15.33
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 15.01
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 14.98
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 14.96
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 14.96
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 14.84
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 14.84
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 14.34
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 14.34
Paxillin regulates genomic networks in prostate cancer [C4-2] 13.87
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 13.77
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 13.64
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 13.26
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 13.13
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 13.07
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 12.99
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 12.99
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 12.93
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 12.39
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 12.37
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 12.26
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 12.26
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 12.25
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 12.25
SUV420H2 knockdown in PANC-1 12.13
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 11.86
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 11.81
RIG-I and MDA5 fRIP during KSHV lytic reactivation 11.65
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 11.53
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 11.53
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 11.48
Sensing self and nonself circular RNAs 11.28
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 11.27
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 11.06
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 10.87
HNRNPL and its RNA Targets in Prostate Cancer 10.76
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 10.76
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 10.66
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 10.6
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 10.6
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 10.54
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 10.54
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 10.51
Genome wide expression change by RNF168 knocking down in MCF-7 cells 10.5
Gene expression in PANC1 cells treated with Rakicidin 10.39
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 10.35
SRSF2 mutations impair hematopoiesis and alter exon recognition 10.16
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 10.12
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 10.12
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 10.04
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 10.04
Transcriptome analysis upon C6orf203 silencing 10.01
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 10.0
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 9.95
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 9.9
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 9.9
RNAseq analysis of ESRP regulated splicing events in prostate cancer 9.85
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 9.79
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 9.79
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 9.72
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 9.6
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 9.59
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 9.59
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 9.42
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 9.39
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 9.35
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 9.3
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 9.28
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 9.26
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 9.26
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 9.19
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 9.08
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 9.08
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 8.91
TFAP2C signalling in human fibroblasts 8.91
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 8.87
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.77
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.77
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.75
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 8.72
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 8.72
RNA seq analysis of human Fetal and adult derived Enterospheres 8.66
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.65
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.65
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 8.49
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 8.48
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 8.44
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 8.4
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 8.4
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 8.37
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 8.37
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 8.37
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 8.37
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 8.37
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.31
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.31
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 8.3
Biological effect of chronic mistranslation in mammalian cells 8.29
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 8.27
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 8.22
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 8.2
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 8.2
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 8.14
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 8.11
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 8.07
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 8.07
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 8.07
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 8.05
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 8.04
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 8.03
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 8.0
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 7.93
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 7.92
7.85
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 7.82
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 7.82
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.82
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.82
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.8
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 7.79
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 7.79
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.74
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 7.73
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 7.73
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 7.73
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.69
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.69
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 7.68
PNET animal model: new insights (II) 7.67
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 7.61
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 7.55
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 7.54
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 7.46
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 7.46
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 7.44
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 7.35
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 7.34
Selective suppression of endothelial cytokine production by progesterone receptor 7.34
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 7.3
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 7.24
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 7.15
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 7.11
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 7.09
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 7.03
RNA-sequencing of human tendon after injury 7.01
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.98
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.96
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 6.95
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 6.92
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 6.87
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 6.82
CD74 role in transcription regulation 6.82
CD74 role in transcription regulation [RNA-seq] 6.82
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 6.78
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 6.71
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 6.71
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 6.7
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.68
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 6.67
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 6.65
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 6.65
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 6.65
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 6.58
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 6.58
Dtx3L and Androgen Signaling in Prostate Cancer 6.57
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 6.57
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 6.51
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.44
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 6.42
Glioblastoma stem cells infected by ZIKA virus 6.41
ADAR1-editing of cellular and measles virus-derived duplex RNA 6.4
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 6.4
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 6.39
hTERT promotes cell adhesion and migration independent of telomerase activity 6.37
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.35
Landscape of H3K4me3 in human CD19 cells 6.34
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 6.33
Gene expression analysis in response to hypoxic pathway inhibition 6.31
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 6.27
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 6.27
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.26
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 6.24
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.23
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 6.22
MYC dependent mRNA translation shapes gene expression and cell biology 6.18
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.18
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 6.13
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 6.13
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 6.13
Effect of Influenza virus infection on lncRNA expression in A549 cells 6.12
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 6.12
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.12
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 6.11
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 6.06
Transcriptome analysis of SKI knock-out in HL60 cells 6.06
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 6.06
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 5.99
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 5.95
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 5.94
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 5.93
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.93
Tumor exosome integrins determine organotropic metastasis 5.89
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.88
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 5.86
Expression profiling of etoposide-induced senescent cells 5.73
IMP3 regulated gene expression in breast cancer cells 5.73
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 5.72
Widespread intronic polyadenylation diversifies immune cell transcriptomes 5.72
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 5.71
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 5.71
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 5.71
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.69
Effects of rFVIIIFc on human macrophages 5.68
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 5.67
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 5.61
Transcriptomic profiling of human peripheral blood-derived mast cells 5.57
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.57
Expression profiles of the four human major ectodermal lineages 5.55
MeRIP-seq for heat shock in B-cell lymphoma cells 5.53
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 5.53
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 5.53
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 5.53
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.49
Exploring the RNA landscape of endothelial exosomes 5.49
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.48
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.48
TT-Seq captures the human transient transcriptome 5.46
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 5.45
RNA-sequencing in irradiated and normal A549 cells. 5.39
Loss of CREBBP results in gene expression repression in lymphoma cells 5.37
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.37
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 5.34
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 5.34
Gene expression profile of multiple myeloma cell lines treated with CB-5083 5.27
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 5.25
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.24
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 5.24
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 5.2
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.19
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.18
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.18
Role of XRN2 ribonucleolytic activity in RNA metabolism 5.12
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 5.11
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 5.08
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.07
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 5.04
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 5.01
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.0
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.0
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.98
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 4.96
Androgen Receptor-regulated genes in prostate cancer cells 4.96
Transcriptome of U251 cells overexpression complement component 7 4.93
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 4.91
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.91
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.88
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.88
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 4.87
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 4.85
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 4.85
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 4.84
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 4.84
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.83
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.83
N6-methyladenine DNA Modification in Glioblastoma 4.83
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.83
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.78
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 4.73
Tyrosine Kinase Inhibitor Cardiotoxicity 4.73
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 4.7
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.7
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 4.68
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 4.68
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.66
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.63
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 4.58
K562 polyA RNA-Seq 4.58
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 4.55
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 4.53
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 4.51
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.46
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.46
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 4.44
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.39
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 4.36
Primary Human B-cell Temporal Response to CD40L Stimulation 4.35
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.32
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.32
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.32
Downregulation of DDX5/DDX17 and REST 4.3
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 4.28
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 4.21
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.18
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.18
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 4.16
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.14
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.14
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 4.08
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 4.03
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 4.03
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 4.01
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.99
Induced DNA demethylation, genome instability and transcription 3.98
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 3.98
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 3.98
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 3.97
ARS2 is a general suppressor of pervasive transcription [RNAseq] 3.92
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.89
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.88
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 3.88
miR-93 Targets in Human Endothelial Cells 3.86
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.85
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.85
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 3.82
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.77
Illumina Total RNA-seq in HeLa 3.71
FOXP1 orchestration of ASD-relevant signaling pathways. 3.63
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 3.61
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.56
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.56
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 3.54
Effect of from Human Umbilical Vein Endothelial Cells 3.54
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.52
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.52
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.51
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.51
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.51
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 3.49
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.49
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.49
MicroRNA-125a-5p overexpression in human macrophages 3.48
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 3.48
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.45
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 3.42
Targeted enhancer activation by a subunit of the integrator complex 3.35
Macrophage Ad5f35 M2 Challenge 3.35
Genome-wide analysis of the Integrator complex (HTS) 3.34
Genome-wide analysis of the Integrator complex 3.34
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 3.25
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 3.23
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 3.22
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.21
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 3.21
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 3.18
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  3.16
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 3.14
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.13
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 3.1
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 3.05
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.05
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.02
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.02
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.01
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.99
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.97
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 2.96
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.95
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 2.95
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.8
Capturing the Interactome of Newly Transcribed RNA 2.8
Impact on erythroid progenitor type on erythroid differntiation 2.79
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.74
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.62
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 2.62
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.61
Changes in human endometrial gland transcriptome over the window of implantation 2.59
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.57
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.52
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.52
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.5
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.48
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 2.46
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 2.43
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.41
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.39
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.34
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.32
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 2.3
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 2.29
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 2.29
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 2.27
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.23
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.23
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.23
RNA-seq of SCLC PDX models treated with EP 2.17
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.17
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.09
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.07
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.06
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 2.06
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.0
Epigenomic conservation of transposable element silencing [RNA-seq] 2.0
Epigenomic conservation of transposable element silencing 2.0
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.98
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.98
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.95
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.93
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.88
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 1.88
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.77
Deep RNA sequencing of the human placental transcriptome 1.75
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.7
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.7
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.7
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.59
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.57
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.56
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 1.56
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.5
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.5
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.49
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.49
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.49
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.47
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.45
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.42
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.34
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 1.33
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.32
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 1.29
RNAseq of Breast cancer PDX samples 1.27
U2AF1 mutations alter splice site recognition in hematological malignancies 1.24
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.24
Gene expression profile of CRC-derived HILEC 1.09
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.05
The MEF2B Regulatory Network 1.05
The MEF2B Regulatory Network - RNA-seq data 1.05
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 0.99
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.94
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.94
RNA-seq of primary patient AML samples 0.91
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.88
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.88
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.82
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.82
Dermal endothelial cells of type 2 diabetic patients 0.69
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.69
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.68
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.62
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.56
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.53
Regulation of poly(A) tail and translation during the somatic cell cycle 0.48
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.48
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.48
The pioneer factor CEBPA modulates vitamin D signaling 0.48
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.47
The role of m6A/m-RNA methylation in stress response regulation 0.47
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.44
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.4
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 0.39
Genome wide miR-191 target profile determined by RIP and gene expression profiling 0.39
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.35
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.33
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.33
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.3
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.28
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.28
Interphase condensins regulate ligand-depedent enhancer activation 0.28
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.27
Transcriptomic analysis of human macrophages in 3D 0.25
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.25
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.24
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.24
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.24
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.24
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.23
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.18
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.15
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.14
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.11
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.08
Polarized B -cell functions 0.06


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation